166 related articles for article (PubMed ID: 36059710)
1. Dose rate and dose robustness for proton transmission FLASH-RT treatment in lung cancer.
Wei S; Lin H; Huang S; Shi C; Xiong W; Zhai H; Hu L; Yu G; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
Front Oncol; 2022; 12():970602. PubMed ID: 36059710
[TBL] [Abstract][Full Text] [Related]
2. Advanced pencil beam scanning Bragg peak FLASH-RT delivery technique can enhance lung cancer planning treatment outcomes compared to conventional multiple-energy proton PBS techniques.
Wei S; Lin H; Isabelle Choi J; Shi C; Simone CB; Kang M
Radiother Oncol; 2022 Oct; 175():238-247. PubMed ID: 35961583
[TBL] [Abstract][Full Text] [Related]
3. A Novel Proton Pencil Beam Scanning FLASH RT Delivery Method Enables Optimal OAR Sparing and Ultra-High Dose Rate Delivery: A Comprehensive Dosimetry Study for Lung Tumors.
Wei S; Lin H; Choi JI; Simone CB; Kang M
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830946
[TBL] [Abstract][Full Text] [Related]
4. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
[TBL] [Abstract][Full Text] [Related]
5. FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification.
Wei S; Lin H; Choi JI; Press RH; Lazarev S; Kabarriti R; Hajj C; Hasan S; Chhabra AM; Simone CB; Kang M
Front Oncol; 2021; 11():813063. PubMed ID: 35096620
[TBL] [Abstract][Full Text] [Related]
6. Pencil Beam Scanning Proton Bragg Peak Conformal FLASH in Prostate Cancer Stereotactic Body Radiotherapy.
Kaulfers T; Lattery G; Cheng C; Zhao X; Selvaraj B; Wu H; Chhabra AM; Choi JI; Lin H; Simone CB; Hasan S; Kang M; Chang J
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398188
[TBL] [Abstract][Full Text] [Related]
7. A novel dose rate optimization method to maximize ultra-high dose rate coverage of critical organs-at-risk without compromising dosimetry metrics in proton pencil beam scanning FLASH radiotherapy.
Zhao X; Huang S; Lin H; Choi JI; Zhu K; Simone CB; Yan X; Kang M
Int J Radiat Oncol Biol Phys; 2024 Jun; ():. PubMed ID: 38879087
[TBL] [Abstract][Full Text] [Related]
8. A Universal Range Shifter and Range Compensator Can Enable Proton Pencil Beam Scanning Single-Energy Bragg Peak FLASH-RT Treatment Using Current Commercially Available Proton Systems.
Kang M; Wei S; Choi JI; Lin H; Simone CB
Int J Radiat Oncol Biol Phys; 2022 May; 113(1):203-213. PubMed ID: 35101597
[TBL] [Abstract][Full Text] [Related]
9. Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.
Shang H; Pu Y; Chen Z; Wang X; Yuan C; Jin X; Liu C
ACS Sens; 2021 Feb; 6(2):408-417. PubMed ID: 33125211
[TBL] [Abstract][Full Text] [Related]
10. Technical note: Dosimetry and FLASH potential of UHDR proton PBS for small lung tumors: Bragg-peak-based delivery versus transmission beam and IMPT.
van Marlen P; van de Water S; Slotman BJ; Dahele M; Verbakel W
Med Phys; 2024 May; ():. PubMed ID: 38795376
[TBL] [Abstract][Full Text] [Related]
11. Pencil Beam Scanning Bragg Peak FLASH Technique for Ultra-High Dose Rate Intensity-Modulated Proton Therapy in Early-Stage Breast Cancer Treatment.
Lattery G; Kaulfers T; Cheng C; Zhao X; Selvaraj B; Lin H; Simone CB; Choi JI; Chang J; Kang M
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760528
[TBL] [Abstract][Full Text] [Related]
12. Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams.
van Marlen P; Dahele M; Folkerts M; Abel E; Slotman BJ; Verbakel WFAR
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):621-629. PubMed ID: 31759074
[TBL] [Abstract][Full Text] [Related]
13. Feasibility study of hybrid inverse planning with transmission beams and single-energy spread-out Bragg peaks for proton FLASH radiotherapy.
Ma C; Yang X; Chang CW; Liu R; Bohannon D; Lin L; Liu T; Tian S; Zhou J
Med Phys; 2023 Jun; 50(6):3687-3700. PubMed ID: 36932635
[TBL] [Abstract][Full Text] [Related]
14. Pencil-beam Delivery Pattern Optimization Increases Dose Rate for Stereotactic FLASH Proton Therapy.
José Santo R; Habraken SJM; Breedveld S; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):759-767. PubMed ID: 36057377
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Assessment of 3D Dose Rate for Proton Pencil Beam Scanning FLASH Radiotherapy and Its Application for Lung Hypofractionation Treatment Planning.
Kang M; Wei S; Choi JI; Simone CB; Lin H
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298762
[TBL] [Abstract][Full Text] [Related]
16. Impact of errors in spot size and spot position in robustly optimized pencil beam scanning proton-based stereotactic body radiation therapy (SBRT) lung plans.
Rana S; Rosenfeld AB
J Appl Clin Med Phys; 2021 Jul; 22(7):147-154. PubMed ID: 34101334
[TBL] [Abstract][Full Text] [Related]
17. Proton Bragg Peak FLASH Enables Organ Sparing and Ultra-High Dose-Rate Delivery: Proof of Principle in Recurrent Head and Neck Cancer.
Pennock M; Wei S; Cheng C; Lin H; Hasan S; Chhabra AM; Choi JI; Bakst RL; Kabarriti R; Simone Ii CB; Lee NY; Kang M; Press RH
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568644
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
19. Comparing photon and proton-based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability.
Goddard LC; Brodin NP; Bodner WR; Garg MK; Tomé WA
Br J Radiol; 2018 May; 91(1085):20180010. PubMed ID: 29436852
[TBL] [Abstract][Full Text] [Related]
20. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
